S. Allen

S. Fishbane, K. Jhaveri, S. Allen, 2014, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Thalidomide alone or in combination with fludarbabine are effective treatments for patients with fludarabine-relapsed and refractory CLL

J. Leonard, J. Gabrilove, R. Furman, 2005 .

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma.

S. Steinberg, Sonali M. Smith, E. Jaffe, 2011, Blood.

Subcutaneous Injections of Low Doses of Humanized Anti-CD20 Veltuzumab for Treatment of Indolent B-Cell Malignancies.

R. Elstrom, K. Rai, D. Goldenberg, 2009 .

Pharmacokinetics of low-dose 1-beta-D-arabinofuranosylcytosine given by continuous intravenous infusion over twenty-one days.

D. Budman, V. Vinciguerra, S. Allen, 1985, Cancer research.

Final Results of a Phase 2 NCI Multicenter Study of Romidepsin in Patients with Relapsed Peripheral T-Cell Lymphoma (PTCL).

Elaine S. Jaffe, Steven L. Allen, Sonali M. Smith, 2008 .

Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab.

J. Salmon, I. Shapira, S. Allen, 2012, Arthritis and rheumatism.

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

D. Neuberg, B. Ebert, N. Lindeman, 2015, Blood.

Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia.

P. Venugopal, D. Neuberg, M. Tallman, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma.

S. Steinberg, J. Leonard, E. Jaffe, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Aggressive phase multiple myeloma: a terminal anaplastic transformation resembling high-grade lymphoma.

S. Allen, M. Coleman, Steven L. Allen, 1990, Cancer investigation.

A phase II trial of didemnin B in myeloma

B. Peterson, R. Weiss, C. Schiffer, 1994, Investigational New Drugs.

Effect of tetrahydrouridine on the clinical pharmacology of 1-beta-D-arabinofuranosylcytosine when both drugs are coinfused over three hours.

D. Budman, S. Allen, S. Lichtman, 1988, Cancer research.

Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus

S. Allen, Samrah Ahmad, K. Patel, 2016, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621.

M. Caligiuri, C. Bloomfield, R. Larson, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recombinant interleukin‐2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: Results from Cancer and Leukemia Group B 19808

M. Caligiuri, C. Bloomfield, R. Vij, 2013, Cancer.

Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA).

B. Lakshmi, J. Troge, B. Yamrom, 2009, Blood.

CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.

N. Chiorazzi, K. Rai, S. Allen, 2007, Blood.

Clinical and laboratory parameters that define clinically relevant B-CLL subgroups.

N. Chiorazzi, M. Ferrarini, S. Allen, 2005, Current topics in microbiology and immunology.

Biology and treatment of chronic lymphocytic leukemia.

T. Kipps, N. Chiorazzi, K. Rai, 2003, Hematology. American Society of Hematology. Education Program.

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

L. Rassenti, T. Kipps, N. Chiorazzi, 1998, The Journal of clinical investigation.

TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells

T. Stankovic, N. Chiorazzi, K. Rai, 2015, The Journal of Immunology.

Binding of CLL Subset 4 B Cell Receptor Immunoglobulins to Viable Human Memory B Lymphocytes Requires a Distinctive IGKV Somatic Mutation

K. Stamatopoulos, Xiao-Jie Yan, N. Chiorazzi, 2017, Molecular medicine.

Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia

Steven L. Allen, Fabio Ghiotto, R. Foà, 2004, The Journal of experimental medicine.

Anna Tramontano, Fabio Ghiotto, M. Nardini, 2004, The Journal of clinical investigation.

In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia.

N. Chiorazzi, K. Rai, J. Kolitz, 2009, Blood.

IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions.

Xiao-Jie Yan, N. Chiorazzi, K. Rai, 2012, Blood.

Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone.

N. Chiorazzi, K. Rai, E. Albesiano, 2003, Blood.

Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6-deficient process.

Xiao-Jie Yan, N. Chiorazzi, K. Rai, 2016, JCI insight.

and Treatment of Chronic Lymphocytic Leukemia

T. Kipps, N. Chiorazzi, K. Rai, 2003 .

Chronic Lymphocytic Leukemia B Cells Can Undergo Somatic Hypermutation and Intraclonal Immunoglobulin VHDJH Gene Diversification

Xiao-Jie Yan, N. Chiorazzi, P. Casali, 2002, The Journal of experimental medicine.

Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia

N. Chiorazzi, D. Budman, V. Vinciguerra, 1989, The Journal of experimental medicine.

Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations.

P. Gregersen, F. Batliwalla, N. Chiorazzi, 2004, Blood.

B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes.

Xiao-Jie Yan, N. Chiorazzi, K. Rai, 2002, Blood.

Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target

O. Abdel-Wahab, Xiao-Jie Yan, N. Chiorazzi, 2021, Leukemia.

A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease.

Annette Lee, P. Gregersen, Xiao-Jie Yan, 2011, Blood.

Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin.

N. Chiorazzi, K. Rai, J. Kolitz, 2010, Blood.

Multi-Parameter Phenotypic Analysis of Members of Chronic Lymphocytic Leukemia Clones Identifies Distinct Proliferative and Resting/Re-Entry Compartments with Discrete Gene Expression Profiles.

Wentian Li, Xiao-Jie Yan, N. Chiorazzi, 2009 .

Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells.

Wentian Li, N. Chiorazzi, S. Stilgenbauer, 2009, Blood.

Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical Course

N. Chiorazzi, S. Bruno, S. Kasar, 2021, Frontiers in Oncology.

G. Gaidano, N. Chiorazzi, K. Rai, 2006, Molecular medicine.

From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use only.

Xiao-Jie Yan, N. Chiorazzi, K. Rai, 2007 .

Primary multicystic undifferentiated embryonal sarcoma of the liver in an adult presenting with peripheral eosinophilia.

S. Ali, S. Teichberg, S. Allen, 1994, Annals of clinical and laboratory science.

Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumors.

J. Kolitz, D. Budman, V. Vinciguerra, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer.

C. Croce, N. Chiorazzi, F. Bullrich, 1995, Cancer research.

Surface Expression of Bcl-2 in Chronic Lymphocytic Leukemia and Other B-Cell Leukemias and Lymphomas Without a Breakpoint t(14;18)

C. Croce, B. McCarthy, Xiao-Jie Yan, 2008, Molecular medicine.

Multiplex accurate sensitive quantitation (MASQ) with application to minimal residual disease in acute myeloid leukemia

A. Krasnitz, J. Kendall, M. Wigler, 2020, Nucleic acids research.

CLL intraclonal fractions exhibit established and recently acquired patterns of DNA methylation.

J. Martinez-Climent, Xiao-Jie Yan, N. Chiorazzi, 2020, Blood advances.

Light chain Fanconi syndrome in a patient with acute myeloid leukemia and monoclonal gammopathy of undetermined significance

K. Jhaveri, R. Wanchoo, S. Allen, 2016, CEN Case Reports.

mouse bladder gene regulation Neurokinin 1 receptors and neprilysin modulation of

Wentian Li, Xiao-Jie Yan, N. Chiorazzi, 2013 .

Phase II trial of romidepsin (FK228 or depsipeptide) in peripheral T-cell lymphoma: clinical activity and molecular markers

M. Turner, R. Piekarz, R. Frye, 2009 .

First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia.

J. Kolitz, J. Lancet, L. Mayer, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin

D. Budman, M. Schuster, S. Allen, 2004, Cancer Chemotherapy and Pharmacology.

Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemia.

J. Bennett, J. Kolitz, A. Lundberg, 2010, Leukemia research.

T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.

N. Chiorazzi, K. Rai, J. Kolitz, 2012, Blood.

Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells

N. Chiorazzi, M. Dono, M. Ferrarini, 1995, The Journal of experimental medicine.

BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study.

M. Caligiuri, C. Bloomfield, A. de la Chapelle, 2003, Blood.

Chronic lymphocytic leukemia immunoglobulins display bacterial reactivity that converges and diverges from auto-/poly-reactivity and IGHV mutation status.

N. Chiorazzi, K. Rai, J. Kolitz, 2016, Clinical immunology.

Chronic Lymphocytic Leukemia Cells Recognize Conserved Epitopes Associated with Apoptosis and Oxidation

E. Meffre, N. Chiorazzi, K. Rai, 2008, Molecular medicine.

Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia.

Wentian Li, Xiao-Jie Yan, N. Chiorazzi, 2011, Blood.

Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study.

J. Bennett, R. Stone, A. Lundberg, 2009 .

A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes

Wentian Li, Mike Tipping, B. McCarthy, 2015, Immunologic Research.

Cytoplasmic myosin exposed apoptotic cells appear with caspase-3 activation and enhance CLL cell viability

N. Chiorazzi, K. Rai, J. Kolitz, 2015, Leukemia.

IGHV1-69 B Cell Chronic Lymphocytic Leukemia Antibodies Cross-React with HIV-1 and Hepatitis C Virus Antigens as Well as Intestinal Commensal Bacteria

H. Liao, B. Haynes, Xiao-Jie Yan, 2014, PloS one.

Amonafide: a potential role in treating acute myeloid leukemia

A. Lundberg, S. Allen, Steven L Allen, 2011, Expert opinion on investigational drugs.

Clinical pharmacokinetics of amonafide (NSC 308847) in 62 patients.

M. Spigelman, D. Budman, A. Calabro, 1996, Cancer investigation.

Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen.

M. Pasmantier, R. Silver, J. Laurence, 1982, Annals of internal medicine.

Dendritic Cells from Chronic Lymphocytic Leukemia Patients Are Normal Regardless of Ig V Gene Mutation Status

N. Chiorazzi, K. Rai, B. Messmer, 2004, Molecular medicine.

rearrangement recognize nonmuscle myosin heavy chain IIA Chronic lymphocytic leukemia antibodies with a common stereotypic

Xiao-Jie Yan, N. Chiorazzi, K. Rai, 2013 .

CD38 Expression Identifies an Active Subset of Proliferating Cells within the Clonal Population in Chronic Lymphocytic Leukemia Patients (In Vitro Analysis).

N. Chiorazzi, K. Rai, S. Allen, 2006 .

In-vitro synergism of m-TOR inhibitors, statins, and classical chemotherapy: potential implications in acute leukemia

D. Budman, A. Calabro, S. Allen, 2008, Anti-cancer drugs.

Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis

T. Bradley, S. Allen, A. Keyzner, 2015, Leukemia research reports.

Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all‐trans retinoic acid and arsenic trioxide

F. Lo‐Coco, H. Kantarjian, J. Cortes, 2015, British journal of haematology.

Clinical and morphological features of cases of trisomy 13 in acute non-lymphocytic leukemia.

K. Rai, P. Koduru, J. Kolitz, 1996, Leukemia.

A novel t ( 11 ; 14 ) ( q 13 ; q 32 ) translocation involving Pellino 3 links innate immune and inflammatory signaling to a myeloproliferative neoplasm

G. Kandala, C. Devoe, Xinmin Zhang, 2016 .

Update of the NCI multiinstitutional phase II trial of romidepsin, FK228, for patients with cutaneous or peripheral T-cell lymphoma

T. Fojo, S. Bates, L. Hutchins, 2007 .

Final Clinical Results of a Phase 2 NCI Multicenter Study of Romidepsin in Recurrent Cutaneous T-Cell Lymphoma (Molecular Analyses Included).

J. Leonard, S. Bates, L. Hutchins, 2008 .

Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Steven L. Allen, Fabio Ghiotto, N. Chiorazzi, 1999, Blood.

Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.

D. Berry, H. Parnes, L. Norton, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I/II study of cyclophosphamide, doxorubicin, fluorouracil, and leucovorin for treatment of metastatic adenocarcinoma.

H. Parnes, J. Abrams, J. Aisner, 1991, Journal of the National Cancer Institute.

Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor β chain and KIT V654A

S. Lowe, M. Spector, I. Iossifov, 2012, Leukemia.

Thalidomide Is Active Alone and in Combination with Fludarabine in Fludarabine-Relapsed and Refractory Chronic Lymphocytic Leukemia.

J. Leonard, J. Gabrilove, R. Furman, 2004 .

Acute basophilic leukemia associated with loss of gene ETV6 and protean complications.

P. Koduru, S. Teichberg, S. Allen, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and Safety of Hydroxychloroquine Sulphate In Chronic Lymphocytic Leukemia: Clinical Trial Experience In Untreated Patients

N. Chiorazzi, K. Rai, J. Kolitz, 2010 .

A novel splicing mutation in the gene encoding the chromatin-associated factor ATRX associated with acquired hemoglobin H disease in myelodysplastic syndrome (ATMDS)

D. Higgs, D. Steensma, C. Fisher, 2004 .

Expression of CD38 and High Levels of CD5 Identifies Members of CLL Clones That Have Progressed beyond G1 and Proliferated.

N. Chiorazzi, K. Rai, M. Hellerstein, 2007 .

Completion of the First Cohort of Patients with Cutaneous T-Cell Lymphoma Enrolled on a Phase II Trial of Depsipeptide.

S. Bates, M. Turner, J. Wright, 2005 .

Correction to: Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells

Wentian Li, Xiao-Jie Yan, N. Chiorazzi, 2022, Molecular Medicine.

Somatic Hypermutation In Stereotyped Subset 4 BCRs/mAbs of CLL Patients, Expressing IGHV4-34 gene, Edit Anti-DNA Reactivity

K. Stamatopoulos, N. Chiorazzi, K. Rai, 2010 .

Low-Dose Ara-C by Continuous Infusion in the Treatment of Acute Non-Lymphocytic Leukemia (ANLL) and Myelodysplastic Syndrome (MDS)

D. Budman, V. Vinciguerra, S. Allen, 1986 .

Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells.

Wentian Li, N. Chiorazzi, S. Stilgenbauer, 2009, Blood.

Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations.

P. Gregersen, F. Batliwalla, N. Chiorazzi, 2004, Blood.

TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells

T. Stankovic, N. Chiorazzi, K. Rai, 2015, The Journal of Immunology.

Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance

A. Rosenwald, N. Chiorazzi, K. Rai, 2012, Haematologica.

Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.

Xiao-Jie Yan, N. Chiorazzi, K. Rai, 2008, Blood.

Chronic Lymphocytic Leukemia Cells Recognize Conserved Epitopes Associated with Apoptosis and Catabolic Chemical Modifications

E. Meffre, N. Chiorazzi, K. Rai, 2008 .

Induction of Apoptosis in CLL by Peptides Binding the B-Cell Antigen Receptor in Vitro

H. Döhner, N. Chiorazzi, S. Stilgenbauer, 2008 .

Surface Expression of Bcl-2 in Chronic Lymphocytic Leukemia and Other B-Cell Leukemias and Lymphomas Without a Breakpoint t(14;18)

C. Croce, B. McCarthy, Xiao-Jie Yan, 2008, Molecular medicine.

Phase II Trial of Romidepsin, FK228, in Cutaneous and Peripheral T-Cell Lymphoma: Clinical Activity and Molecular Markers.

T. Fojo, S. Bates, M. Turner, 2006 .

Lenalidomide Promotes The Expansion Of CD8 T Cells With An Effector Memory Phenotype In a Murine Xenograft Model Of Chronic Lymphocytic Leukemia

Xiao-Jie Yan, N. Chiorazzi, K. Rai, 2013 .